Posted on February 28, 20252/28/25
Successfully Navigating the Complexity of Market Access Across Europe to Improve Health Equity
Posted on February 21, 20252/21/25
Transformative Commercialization for New Biopharma Entrants: Ensuring Success With Capital and Time Efficiency
Posted on January 8, 20251/8/25
The Evolution of Digital Health Policy: A 2024 Retrospective and 2025 Outlook
Posted on September 30, 20249/30/24
Unlocking the Power of Tender Data to Drive Post-LOE Pricing Strategy
Posted on September 23, 20249/23/24
Launching in the EU/U.K.: The 7-Step Countdown to Success
Posted on August 13, 20248/13/24
IDN Trends, Insights and Strategies Every Manufacturer Should Know
Posted on July 11, 20247/11/24
Key Insights from ARCS 2024: Shaping the Future of HTA and Reimbursement in Australia
Posted on July 8, 20247/8/24
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Posted on June 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on June 24, 20246/24/24